2022 Viral Hepatitis Surveillance Status Report
This infographic is an assessment of the status of viral hepatitis surveillance practices across U.S. jurisdictions in 2022.
Viral Hepatitis
Back to Results
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use.
Community-Based Participatory Research (CBPR) in Harm Reduction Settings
This toolkit is for harm reduction workers who are considering participating in research activities, or who already have existing community-academic research partnerships. It may also be of use to academic researchers studying issues related to harm reduction, though they are not the main audience for the toolkit.
Hepatitis B in African Immigrant Communities - Educator Training Presentation
A slide set for community health workers, public health professionals, and physicians that includes information on Hepatitis B basics and tips for educating others.
Unlocking Viral Hepatitis Elimination on the African Continent
A webinar from representatives of the Great Lakes Peace Centre, Coalition Against Hepatitis for People of African Origin, and Ubora Foundation that highlights the efforts toward achieving viral hepatitis elimination in Uganda and elsewhere through awareness-raising, and involvement of women, youth, coalitions, community health workers, and others.
Addressing Myths & Misconceptions about Hepatitis B among African Immigrant Communities around the United States
A webinar that explores some of the most widespread misconceptions about Hepatitis B, particularly in African communities around the United States, from a variety of perspectives, including those of healthcare providers and a community health practitioner.
Drug Use and Viral Infections (HIV, Hepatitis) DrugFacts
This publication discusses how people who engage in drug use or high-risk behaviors associated with drug use put themselves at risk for contracting or transmitting viral infections such as HIV/AIDS or hepatitis.
Hepatitis B and HIV Screening, Prevention, and Management for African Immigrants and Refugees in the United States: Barriers and Solutions
A webinar presented by a diverse panel of experts who shared insights about the unique challenges faced by African immigrant and refugee communities in accessing appropriate diagnosis and care for hepatitis B in the United States, and discussed important strategies for reducing the spread of hepatitis B and addressing the epidemic in a holistic way.
Deeper Look: Immunization
This webpage discusses how Hepatitis A and Hepatitis B are preventable through vaccination.
Deeper Look: Opioids
This webpage discusses the opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country. Find helpful infographics at the bottom of the page.